BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28036326)

  • 1. Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.
    Xu T; Jin Z; Yuan Y; Zheng H; Li C; Hou W; Guo Q; Hua B
    PLoS One; 2016; 11(12):e0168408. PubMed ID: 28036326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis.
    Guo Q; Yuan Y; Jin Z; Xu T; Gao Y; Wei H; Li C; Hou W; Hua B
    Biomed Res Int; 2016; 2016():2408645. PubMed ID: 27812528
    [No Abstract]   [Full Text] [Related]  

  • 3. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
    Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
    Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
    Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
    [No Abstract]   [Full Text] [Related]  

  • 7. TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.
    Bu F; Liu X; Li J; Chen S; Tong X; Ma C; Mao H; Pan F; Li X; Chen B; Xu L; Li E; Kou G; Han J; Guo S; Zhao J; Guo Y
    Oncotarget; 2015 Feb; 6(4):2120-33. PubMed ID: 25544767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
    Li YP; Zhu JF; Huang KT; Wang RR; Cai B; Xie H; Chen HD
    Chin Med J (Engl); 2018 Jan; 131(2):188-193. PubMed ID: 29336367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIP30: A Novel Tumor-Suppressor Gene.
    Yu X; Li Z; Wu WK
    Oncol Res; 2014; 22(5-6):339-48. PubMed ID: 26629947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.
    Zhao J; Ni H; Ma Y; Dong L; Dai J; Zhao F; Yan X; Lu B; Xu H; Guo Y
    Hum Pathol; 2007 Feb; 38(2):293-8. PubMed ID: 17097132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIP30 is associated with progression and metastasis of prostate cancer.
    Zhang H; Zhang Y; Duan HO; Kirley SD; Lin SX; McDougal WS; Xiao H; Wu CL
    Int J Cancer; 2008 Aug; 123(4):810-6. PubMed ID: 18528861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of bromodomain protein 4 expression in solid tumor patients: A meta-analysis.
    Wang Y; Wu Y; Jiang J; Zhang Y; Fu Y; Zheng M; Tao X; Yi J; Mu D; Cao X
    Pathol Res Pract; 2022 Jun; 234():153918. PubMed ID: 35561521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
    Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
    Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.
    Zhou J; Yang Y; Zhang Y; Liu H; Dou Q
    PLoS One; 2018; 13(11):e0207473. PubMed ID: 30427932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice.
    Li A; Zhang C; Gao S; Chen F; Yang C; Luo R; Xiao H
    Oncogene; 2013 May; 32(18):2273-81, 2281e.1-12. PubMed ID: 22733137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
    Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
    BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological role of long non-coding RNA taurine upregulated 1 in various human malignancies: A systemic review and meta-analysis.
    Wang X; Chen X; Zhang D; Yang G; Yang Z; Yin Z; Zhao S
    Tumour Biol; 2017 Jul; 39(7):1010428317714361. PubMed ID: 28671045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.